Which is better, KRYS or RMD?

On the Buffett-Fit framework, ResMed Inc. (RMD) currently grades higher than KRYS — 72/100 (B grade) vs 51/100 (C). That said, "better" depends on which framework you trust — KRYS wins on Joel Greenblatt; RMD wins on Warren Buffett, Benjamin Graham, Philip Fisher, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy KRYS or RMD?

This page is an educational comparison, not investment advice. Both KRYS and RMD are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is KRYS better than RMD for value investing?

On the Buffett-style value-investing framework, RMD currently grades higher — 72/100 vs 51/100, a 21-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between KRYS and RMD on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). KRYS currently scores 51/100 (C grade); RMD scores 72/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, KRYS or RMD?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. KRYS and RMD are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, KRYS or RMD?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are KRYS and RMD both Healthcare stocks?

Yes — both Krystal Biotech, Inc. (KRYS) and ResMed Inc. (RMD) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this KRYS vs RMD comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Krystal Biotech

ResMed

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

KRYS

Krystal Biotech

Market cap

$8.83B

Sector

Healthcare

RMD

ResMed

Market cap

$30.18B

Sector

Healthcare

Overall winner

ResMed RMD

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	KRYS	RMD	Winner
Warren Buffett	51C	72B	RMD
Benjamin Graham	74D	75B	RMD
Philip Fisher

Side-by-side metrics

Metric	KRYS	RMD
Market cap	$8.83B	$30.18B
P/E (TTM)	39.9x	19.6x
EV/EBIT	52.9x	17.1x
ROIC (TTM)	13.85%	19.63%
Gross margin	92.79%	61.69%
Net margin	53.92%	27.44%
Revenue CAGR 5y	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

KRYS leads on

Debt / Equity0.0xvs 0.1x+99%
Net margin53.92%vs 27.44%+49%
Gross margin92.79%vs 61.69%+34%

RMD leads on

More like KRYS

KRYS vs HALO KRYS vs LMAT KRYS vs LLY KRYS vs UTHR KRYS vs HAE KRYS vs IDXX

More like RMD

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.